Oramed Pharmaceuticals Newsroom

H.C. Wainwright Maintains Oramed Pharmaceuticals(ORMP.US) With Hold Rating

Futu NewsSep 9 18:33

Oramed Pharmaceuticals Analyst Ratings

BenzingaSep 9 18:12

Oramed Pharmaceuticals Analyst Ratings

BenzingaMay 20 19:25

Canaccord Genuity Adjusts Price Target on Oramed Pharmaceuticals to $2 From $3, Maintains Hold Rating

MT NewswiresMay 17, 2023 22:24

Canaccord Genuity Maintains Hold on Oramed Pharmaceuticals, Lowers Price Target to $2

BenzingaMay 17, 2023 22:08

Oramed Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsJan 17, 2023 19:16

Cantor Fitzgerald Downgrades Oramed Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $5 From $20

MT NewswiresJan 12, 2023 22:21

Oramed Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsJan 12, 2023 19:51

H.C. Wainwright Sticks to Its Buy Rating for Oramed Pharmaceuticals (ORMP)

TipRanksJan 3, 2023 19:20